Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
Condition: Chronic Hepatitis b Interventions: Drug: ISA104; Drug: Placebo Sponsors: Erasmus Medical Center; ISA Pharmaceuticals B.V. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials